The largest database of trusted experimental protocols

41 protocols using cyclosporin a csa

1

Lifespan and Growth Rate of P. anserina

Check if the same lab product or an alternative is used in the 5 most similar protocols
Determination of the growth rate and lifespan was performed as described in [31 (link)]. Briefly, small mycelium pieces of P. anserina two-day old cultures, which developed from germinated ascospores, were placed on one site of a M2 agar plates and incubated at 27 °C and constant light. When the growth front reached the end of the agar plate, a small piece of mycelium was cut out and transferred to a fresh agar plate. Growth was recorded every day until it stopped. The lifespan of P. anserina is defined as the time period in days (d) of linear hyphal growth while the growth rate is defined as the measured growth (cm) per time period (d).
The impact of cyclosporin A (CsA; Sigma Aldrich, St. Louis, Missouri, USA; C3805) on lifespan was performed on M2 medium supplemented with 0.025 µg/mL cyclosporin A (CsA) dissolved in ethanol (EtOH).
+ Open protocol
+ Expand
2

Stimulation and Inhibition of LRH-1

Check if the same lab product or an alternative is used in the 5 most similar protocols
Phorbol 12-myristate 13-acetate (PMA) and ionomycin were purchased from Enzo Life Sciences (Lörrach, Germany). The LRH-1 inhibitor 3d2 and the control substance compound 7 (cpd7) were re-synthesized according the publication of Benod et al.23 (link) at ChemBridge Corp (San Diego, CA, USA). The LRH-1 inhibitor SR1848, Cyclosporin A (CsA) and Concanavalin A (ConA, Jack bean, Type IV) were obtained from Sigma-Aldrich (Steinheim, Germany). Hamster anti-mouse FasL antibody (MFL3), anti-mCD4-FITC and anti-mCD8-PE were obtained from BD Biosciences (Heidelberg, Germany). Hamster anti-mouse CD3ɛ antibody (clone 145-2C11) was purified from cell culture supernatant and coated to tissue culture plates in 50 mM Tris–HCl pH 9.0 at 4 °C overnight.
+ Open protocol
+ Expand
3

Investigating LCMV Infection and Immune Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
LCMV strains Armstrong (Arm) and clone-13 (Cl-13) were propagated and titers were determined as previously described53 . C57BL/6J mice were infected intraperitoneally (i.p.) with 2×105 plaque-forming units (PFU) of LCMV Arm or intravenously (i.v.) with 4×106 PFU LMCV Cl-13. For other experiments, mice were infected with 2×106 PFU VSV-OVA (i.v.) or 1×104 colony-forming units (CFU) LM-GP33 (i.p.). For influenza infection, mice were anesthetized with isofluorane and ketamine prior to intranasal administration of 50 TCID50 PR8-GP33 (H1N1 strain) in 30μl of PBS. FK506 (Prograf, Astellas Pharma US) was prepared for injection by diluting to 1.5mg/ml in PBS. Diluted FK506 was administered s.c. at a dose of 10mg/kg from d3–7 or d25–29 of LCMV Cl-13 infection54 . Cyclosporin A (CsA, Sigma-Aldrich) was prepared by diluting in sunflower oil (Sigma-Aldrich). 40mg/kg of diluted CsA was administered IP daily for duration of treatment. For control treatments, PBS was administered s.c.
+ Open protocol
+ Expand
4

Pharmacological Modulation of Hippocampal Slices

Check if the same lab product or an alternative is used in the 5 most similar protocols
Drugs were prepared as stock solutions and diluted to the desired final concentration in artificial cerebral spinal fluid (ACSF) containing: 124 mM NaCl, 4.4 mM KCl, 2 mM CaCl2, 2 mM MgSO4, 1mM Na2HPO4, 25 mM NaHCO3, 10mM D-(+)-glucose or sucrose (for glucose-free ACSF), immediately before application. Hippocampal slices with drugs were incubated in recovery or recording sub-immerse chambers as needed. The final concentrations and sources of the drugs were as follows: Cyclosporin A (CSA; 1 μM, Sigma), Ro 25-6981 (Ro25; 1 μM, Sigma), PPPA (0.5 μM; Tocris), Pifithrin-μ (PFT; 5 μM, Sigma), EUK 134 (EUK; 500 nM, Cayman Chemical). The final concentration of vehicle control ethanol was less than 0.5% in all experiments, which is the same concentration of ethanol in the solution containing drugs for the treatment. All reagents were purchased from Sigma (St. Louis, MO) instead of otherwise stated.
+ Open protocol
+ Expand
5

Characterization of CsA Biosynthesis in T. inflatum

Check if the same lab product or an alternative is used in the 5 most similar protocols
The wild-type (WT) strain NRRL 8044 (ATCC 34921) of Tolypocladium inflatum (1 (link)) was used to generate the gene deletion mutants. Both the WT and mutants were maintained either on potato dextrose agar (PDA) (BD Difco) or in a Sabouraud dextrose broth (SDB) (BD Difco). For induction of CsA production, the WT or mutants was induced in the cyclosporine (CSN) induction medium containing fructose (fructose CSN induction medium) [fructose, 30 g/liter; (NH4)2HPO4, 6 g/liter; yeast extract, 5 g/liter; CaCl2·2H2O, 1.32 g/liter; MgSO4·7H2O, 2.05 g/liter; FeSO4·7H2O, 27.4 mg/liter; ZnSO4·7H2O, 17.8 mg/liter; CoCl2·6H2O, 27.5 mg/liter; CuSO4·5H2O, 3.1 mg/liter] adjusted from a previous study (17 (link)). The strains of Aspergillus flavus (NRRL 3357), Metarhizium robertsii (ARSEF 23) (33 (link)), Cordyceps cicadae (CCAD02) (34 (link)), Cordyceps militaris (Cm01) (35 (link)), and Beauveria brongniartii (RCEF 3172) (36 (link)) were used for antifungal assays between WT and null mutants of T. inflatum. The standards of cyclosporin A (CsA) and d-Ala were ordered from Sigma-Aldrich (USA), and CsB and CsC were purchased from Santa Cruz Biotechnology (USA).
+ Open protocol
+ Expand
6

Imaging Mitochondrial Dynamics and mPTP

Check if the same lab product or an alternative is used in the 5 most similar protocols
The imaging procedure followed a previously described method [18 (link)]. Cells were seeded on poly-d-lysine-coated glass coverslips and imaging was performed in Hank’s balanced salt solution (HBSS, Gibco, New York, NY, USA) at room temperature. To track changes in mitochondrial membrane potential, the fluorescent probe tetramethylrhodamine, methyl ester (TMRM, Invitrogen, Waltham, MA, USA) was used. Cells were incubated with 20 nM TMRM for 15 min in the dark at room temperature. Recordings were performed in the presence of 20 nM TMRM.
To induce mitochondrial Ca2+ overload and subsequent mPTP, ferutinin at a concentration of 20 μM was used. RI images (holographic reconstructions) and TMRM signals were acquired every 15 s using a 3D Cell Explorer-fluo (Nanolive, Tolochenaz, Switzerland) equipped with a 60× objective. At the end of each experiment, 10 μM of the protonophore carbonyl cyanide 4-(trifluoromethoxy) phenylhydrazone (FCCP, Sigma Aldrich, St. Louis, MO, USA) was added to induce complete depolarization of mitochondria, allowing for the determination of the minimal TMRM signal for subsequent normalization and analysis.
Cyclosporin A (CSA, Sigma Aldrich, St. Louis, MO, USA) and bongkrekic acid (BA, Sigma Aldrich, St. Louis, MO, USA), inhibitors of mPTP and ANT, respectively, were used to explore the regulation of the mitochondrial permeability transition.
+ Open protocol
+ Expand
7

T Cell Activation Assay with Allogenic DCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
1×105 T cells were co-cultured with either 2×104 allogeneic DCs or glutaraldehyde fixed CHO cells in 96-well plates for 5 days (unless otherwise stated) in RPMI 1640 supplemented with 10% FBS, 50U/mL penicillin and streptomycin and 200μM L-glutamine. Stimulations were treated with anti-CD3 (OKT3; 500ng/mL, unless otherwise stated), anti-CD28 (9.3; 500ng/mL) or toxic shock syndrome toxin (TSST)-1 at indicated concentrations (Toxin Technology, Sarasota, FL, USA). Alternatively, T cells were stimulated for 5 days with Dynabeads® Human T-activator CD3/CD28 beads (Life Technologies). Where indicated stimulations were treated with abatacept (20μg/mL; Bristol Myers Squibb), 1,25(OH)2D3 (10nM; Sigma-Aldrich) or Cyclosporin A (CsA; Sigma-Aldrich). The concentration of 1,25(OH)2D3 used was determined from previous experience (19 (link)) and similar to those used by others (20 (link), 21 (link)). The vehicle for 1,25(OH)2D3 was ethanol, which was diluted to a final concentration of 0.01% (v/v) during experiments; vehicle controls showed no effect upon experimental outcomes. PBS vehicle was used for all other reagents.
+ Open protocol
+ Expand
8

Rhodamine 123 Uptake Assay

Check if the same lab product or an alternative is used in the 5 most similar protocols
The cells were incubated with 10 μM rhodamine 123 (Sigma) in transport buffer (distilled water with 0.12 M NaCl, 25 mM NaHCO3, 3 mM KCl, 2 mM MgSO4, 2 mM CaCl2, 0.4 mM K2HPO4, 1 mM HEPES, and 0.1% BSA) for 2 h at 37 °C. For inhibition experiments, cells were pre-incubated with 10 μM cyclosporin A (CsA; Sigma) for 60 min at 37 °C. Then, cells were washed three times with PBS and lysed with RIPA buffer. Fluorescence was measured using a fluorescence multi-well plate reader (Genios). Fluorescence was normalized on a per cell basis by counting dissociated cells.
+ Open protocol
+ Expand
9

Generating Lymphoblastoid Cell Lines from PBMCs

Check if the same lab product or an alternative is used in the 5 most similar protocols
EBV B95-8 virus was produced from the B95-8 Z-HT cell line, as previously described [36 (link)]. Buffy coats were obtained from normal donors through the Gulf Coast Regional Blood Center and peripheral blood mononuclear cells (PBMCs) were isolated using a Ficoll Histopaque-1077 gradient (Sigma, St. Louis, MO, USA #H8889). Primary human B cells were cultured in Roswell Park Memorial Institute medium (RPMI)1640 supplemented with 15% fetal bovine serum (FBS), 2 mM l-glutamine, penicillin, and streptomycin (1X, Sigma, #G6784) (R15) as well as 0.5 µg/mL Cyclosporin A (CsA) (Sigma, #30024). Bulk infections were performed by incubating cells with B95-8 Z-HT supernatant at 500 μL per 106 B cells calculated from within the PBMC population for 1 h at 37 °C in a CO2 incubator. Incubation was followed by washing in PBS and resuspending in R15 media supplemented with CsA. Bulk infections were conducted on 5 × 108 PBMCs. LCLs were generated from normal donors by continuous outgrowth of EBV-infected primary B cells for greater than 35 days. LCLs were cultured in RPMI media supplemented with 10% FBS (R10). Bloom syndrome (BLM) deficient LCLs (GM16377, GM16375, and GM09960) were obtained from Coriell Institute (Coriell Institute, Camden, NJ, USA).
+ Open protocol
+ Expand
10

Investigating LCMV Infection and Immune Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
LCMV strains Armstrong (Arm) and clone-13 (Cl-13) were propagated and titers were determined as previously described53 . C57BL/6J mice were infected intraperitoneally (i.p.) with 2×105 plaque-forming units (PFU) of LCMV Arm or intravenously (i.v.) with 4×106 PFU LMCV Cl-13. For other experiments, mice were infected with 2×106 PFU VSV-OVA (i.v.) or 1×104 colony-forming units (CFU) LM-GP33 (i.p.). For influenza infection, mice were anesthetized with isofluorane and ketamine prior to intranasal administration of 50 TCID50 PR8-GP33 (H1N1 strain) in 30μl of PBS. FK506 (Prograf, Astellas Pharma US) was prepared for injection by diluting to 1.5mg/ml in PBS. Diluted FK506 was administered s.c. at a dose of 10mg/kg from d3–7 or d25–29 of LCMV Cl-13 infection54 . Cyclosporin A (CsA, Sigma-Aldrich) was prepared by diluting in sunflower oil (Sigma-Aldrich). 40mg/kg of diluted CsA was administered IP daily for duration of treatment. For control treatments, PBS was administered s.c.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!